The blood pressure "uncertainty range" - A pragmatic approach to overcome current diagnostic uncertainties (II)

Current Controlled Trials in Cardiovascular Medicine

Volumn 6, Issue , 2005, Pages

  Pater, Cornel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; INFORMATION SYSTEM; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PUBLIC HEALTH; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; WHITE COAT HYPERTENSION;

EID: 27544483516     PISSN: 14686694     EISSN: 14686694     Source Type: Journal    
DOI: 10.1186/1468-6708-6-5     Document Type: Review

References (103)

1. 3 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003, 21:1011-1053.
2. World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization (WHO/International Society of Hypertension (ISH) statemeot on management of hypertension. J Hypertens 2003, 21:1983-1992.
3. Anderson KV, Odell PM, Wilson PWF, Kannel WB: Cardiovascular disease risk profiles. Am Heart J 1991, 121:293-298.
4. Jackson RJ, Lawes CMM, Bennett DA. Milne RJ, Rodgers A: Treating Individuals 5: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365:434-441.
5. Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM: Beyond hypertension. Toward guidelines for cardiovascular risk reduction. Am J Hypertens 2004, 17(11):1068-1074.
6. Mancia G, Grassi G: Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002, 20:1461-1464.
7. Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
8. Law MR, Wald NJ: Risk factor thresholds; their existence under scrutiny. BMJ 2002, 324:1570-1576.
9. Rodgers A: Quantifying selected major risks to health. In The world health report 2002: reducing risks, promoting healthy life Edited by: Murray CJL, Lopez Ad. Geneva: WHO; 2002:47-92.
10. Neaton JD, Wenthworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum Cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 1992, 152:56-54.
11. Asia Pacific Cohort Studies Collaboration: Cholesterol, coronary heart disease and stroke in the Asia Pacific Region. Int J Epidemiol 2003, 32:563-572.
12. Asia Pacific Cohort Studies Collaboration: Blood pressure and Cardiovascular disease in the Asia Pacific Region. J Hypertens 2003, 21:707-716.
13. Eastern Stroke and Coronary Heart Disease collaborative Research Group: Blood pressure, cholesterol, and stroke in Eastern Asia. Lancet 1998, 352:1801-1807.
14. William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med 2003, 348(24):2377-2378.
15. Little P, Barnet J, Barnsley L, Marjoram J, Fitzgerald-Baron A, Mant D: Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002, 325:254-259.
16. Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stagnoni G: Prognostic value of 24-hour blood pressure in pregnancy. JAMA 1999, 282:1447-1452.
17. Staessen JA, Fagard R, Thjis L: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350:757-764.
18. O'Brian E: Ambulatory blood pressure monitoring in the management ot hypertension. Heart 2003, 89:571-576.
19. MacDonald MB, Laing GP, Wilson MP, Wilson TW: Prevalence and predictors of white-coat response in patients with treated hypertension. Can Med Assoc J 1999, 161:265-269.
20. Pickering T, Davidson K, Gerin W: Masked hypertension. Hypertension 2002, 40:795-796.
21. Guillaume B, Chatellier G, Genes N, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of "Masked Hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004, 291:1342-1349.
22. Guillaume B, Chatellier G, Genes N, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of "Masked Hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004, 291:1342-1349.
23. Mulrow PJ: Hypertension a worldwide epidemic. In Hypertension primer: the essentials of high blood pressure 2nd edition. Edited by: Izzo JL, Black HR, Goodfriend TL. Baltimore: Williams and Wilkins; 1999:721-273.
24. Wolf-Maier K, Cooper RS, Banegas JR, Gianpaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension Prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
25. Kotchen JM, McKean HE, Kotchen TA: Blood pressure trends with aging. Hypertension 1982, 4(suppl 3):11-129.
26. Franklin SS, Larson MG, Khan SA: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framinghan Heart Study. Circulation 2001, 103:1245-1249.
27. Pitt B, Julian D, Pocock S: Clinical Trials in Cardiology WB Saunders Company Ltd., London; 1997.
28. Mower WR: Evaluating bias and variability in diagnostic test reports. Ann Emerg Med 1999, 33:85-91.
29. Patterson RA, Horowitz SE: Importance of epidemiology and biostatistics in deciding clinical strategies for using diagnostic tests: a simplified approach using examples from coronary artery disease. J Am Coll Cardiol 1989, 13:1653.
30. William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med 2003, 348(24):2377-2378.
31. Kottke TE, Stroabel R, Hofman R: JNC-7 it's more than high blood pressure. JAMA 2003, 289(19):2573-2575.
32. Mulrow PJ: Hypertension: a worldwide epidemic. In Hypertension primer: the essentials of high blood pressure 2nd edition. Edited by: Izzo JL, Black HR. Coodfriend TL. Baltimore: Williams and Wilkins; 1999:721-723.
33. Jekel JF, Elmore JG, Katz DL: Epidemiology Biostatistics and Preventive Medicine WB Saunders Company Ltd., Philadelphia; 1996.
34. Meyer D: Essential Evidence-Based Medicine Cambridge University Press, Cambridge; 2004.
35. Campbell NC, Murchie P: Treating hypertension with guidelines in general practice. BMJ 2004, 329:523-524.
36. Wong ND, Black HR, Gardin JM: Preventive Cardiology McGraw Hill companies, Inc., New York; 2000.
37. Alderman M: Blood Pressure Measurement. Individualized Treatment Based on Absolute Risk and the Potential for Benefit. Ann Intern Med 1993, 119:329-335.
38. Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:9343.
39. Alderman MH: Blood Pressure Management: Individualized Treatment Based on Absolute Risk and Potential for Benefit. Ann Intern Med 1993, 119:329-335.
40. Kannel WB: Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976, 37:269-281.
41. Kannel WB, Wolf PA, Verter J, McNamara PM: Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970, 214:301-310.
42. Arauz-Pacheco C, Parrott MA, Raskin P: The Treatment of hypertension in adult patients with diabetes. Diabetes Care 2002, 25(1):134-147.
43. Bakris GL, Weir MR: Achieving goal blood pressure in patients with type 2 diabetes: combination versus fixed-dose combination approaches. J Clin Hypertens 2003, 5(3):202-209.
44. Deedwania PC: Hypertension and diabetes: new therapeutic options. Arch Intern Med 2000, 160:1585-1594.
45. American Diabetes Association: American diabetes Association: clinical practice recommendations 2002. Diabetes Care 2002, 25(suppl 1):S1-S147.
46. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001, 358:1305-1315.
47. Gradman AH, Acevedo C: Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002, 4(5):343-349.
48. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
49. Chobanian AV, BAkris GL, Black HR, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
50. Stamler J, Stamler K, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153:598-625.
51. World Health Organization-International Society of Hypertension Guidelines for Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999, 17:151-183.
52. Hotline Editorial: Rates of progression to hypertension among non-hypertensive subjects: implications for blood pressure screening. Eur Heart J 2002, 23:6067-1070.
53. Vasan RS, Larsan MG, Leip EP, Kannel WB, Levy D: Assessmeat of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001, 358:1682-1686.
54. Pickering TG: Utility of 24-hour ambulatory blood pressure monitoring in clinical practice. Can J Cardiol 1995, 11:43H-48H.
55. Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A: Ambulatory blood pressure monitoring in clinical trials. J Hypertens Suppl 1991, 9(suppl 1):S13-S19.
56. Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A: Reference values for ambulatory blood pressure: a meta-analysis. J Hypertens 1990, 8(suppl 6):S57-S64.
57. O'Brien E, Murphy J, Tyndall A: Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens 1990, 9:355-360.
58. ISH Scientific Committee: Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens 1990, 8(suppl 6):S136-S140.
59. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G: Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001, 104:1385-1392.
60. Selenta C, Hogan BE, Linden W: How Often Do Office Blood Pressure Measurements Fail to Identify True Hypertension? An Exploration of White-Coat Normotension. Arch Fam Med 2000, 9:533-540.
61. Prisant LM: Ambulatory blood pressure monitoring in the diagnosis of hypertension. Cardiol Clin 1995, 13:479-490.
62. O'Brien E, Mee F, Atkins N, O'Malley K: Accuracy of the Spacelabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991, 5:573-574.
63. Liu JE, Roman NJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Elevated ambulatory with normal clinic blood pressure ("white coat normotension") is associated with cardiac and arterial target organ damage. Ann Intern Med 1999, 131:564-572.
64. Pickering TG, James GD, Boddie C, Harsfield GA, Blank S, Laragh JH: How common is white-coat hypertension? JAMA 1988, 259:225-228.
65. Staessen JA, Thijs L, Fagard R, for the Systolic Hypertension in Europe Trial Investigators, et al.: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539-546.
66. White WB, Schulman P, McCabe EJ, Dey HM: Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension. JAMA 1989, 261:873-877.
67. Mancia G, Zanchetti A: White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens 1996, 14:1049-1052.
68. Verdecchia P, Clement D, Fagard R. Palatini P, Parati G: Target organ damage, morbidity and mortality. Blood Pressure Monitoring 1999, 4:303-317.
69. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P, Task Force V: White-coat hypertension. Blood Pressure Monitoring 1999, 4:333-341.
70. William BW: Ambulatory blood-pressure monitoring in clinical practice. New Engl J Med 2003, 348(24):2377-2378.
71. Little P, Barnet J, Barnsley L, Marjoram J, Fitzgerald-Baron A, Mant D: Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002, 325:254-259.
72. Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stagnoni G: Prognostic value of 24-hour blood pressure in pregnancy. JAMA 1999, 282:1447-1452.
73. Mancia G, Bertineri C, Grassi G: Effects of blood pressure measured by the doctor on patient's blood pressure and heart rate. Lancet 1963, 2:695-698.
74. Myers MG, Haynes B, Rabbkin SW: Canadian Hypertension Society Guidelines for Ambulatory Blood Pressure Monitoring. Am J Hypertens 1999, 12:1149-1157.
75. Myers MG, Reeves RA: White-coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991, 4:844-849.
76. Myers MG, Reeves RA: White-coat effect in treated hypertensive patients: sex difference. J Hum Hypertens 1995, 9:729-733.
77. O'Brien E: Ambulatory blood pressure monitoring in the management of hypertension. Heart 2003. 89:571-576.
78. Brawn LA, Castleden CM: Adverse drug reactions: an overview of special considerations in the management of the elderly patient. Drug Safety 1990, 5:421-435.
79. Rochon PA, Anderson GM, Tu JV: Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc 1999, 47:954-959.
80. Tomlinson B: Optimal dosage of ACE inhibitors in older patients. Drugs Aging 1996, 9:262-273.
81. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413-1446.
82. Guidelines Subcommittee: 1999 WHI/ISH Guidelines for the management of hypertension. J Hypertens 1999, 17:151-183.
83. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russel G: British Hypertension Society Guidelines for hypertension management 1999: summary. Br Med J 1999 519:17630-635.
84. Centers for Medicare & Medicaid Services: Medicare coverage policy - decisions. ABPM monitoring (#CAG-00067N) 2001 [http://www.hcfa.gov/coverage/8b3-ff.htm].
85. Krishan G: Isolated Office Hypertension: Ambulatory BP Monitoring Is the Only Answer. Arch Intern Med 2002, 162(13):1526.
86. Staessen JA, O'Brien E, Thijs L, Fagard RH: Modern approaches to blood pressure measurement. Occup Environ Med 2000, 57:510-520.
87. Ferrucci L, Furberg CD, Penninx BW: Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001, 104:1923-1926.
88. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP: A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomized controlled trials. BMJ 2001, 323:75-81.
89. O'Rourke J, Richardson SW: Evidence based management of hypertension: what to do when blood pressure is difficult to control. BMJ 2001, 322:1229-1232.
90. Pickering TG: Ambulatory blood pressure monitoring. Curr Hypertens Rep 2000, 2:558-564.
91. Prasad N, Isles C: Ambulatory blood pressure monitoring: a guide for general practitioners. BMJ 1996, 313:1535-1541.
92. O'Brien E, Coats A, Owens P, Petries J, Padfield P, Littler W: Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000, 320:1128-1134.
93. Ramsey L, Williams B, Johnson G, MacGregor GA, Poston L, Potter J: Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999, 13:569-592.
94. Devereux RB, Pickering TG: Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens Suppl 1991, 9(suppl 8):S34-S38.
95. Giaconi S, Levanti C, Fommei E: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989, 2:259-261.
96. Shimada K, Kawanato A, Matsubayishi K, Ozawa T: Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension 1990, 16:692-699.
97. Mancia G, Zanchetti A, Agebiti-Rosei E: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left-ventricular hypertrophy. Circulation 1997, 95:1464-1470.
98. Ohkubo T, Imai Y, Tsuji I: Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997, 15:357-364.
99. Staessen JA, Thijs L, Fagard R: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539-546.
100. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 1983, 249:2792-2798.
101. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM: Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998, 31:712-718.
102. Verdecchia P, Porcellati C, Schillaci G: Ambulatory blood prussure, an independent predictor of prognosis in essential hypertension. Hypertension 1994, 24:793-801.
103. Ernst EE, Bergus GR: Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectionall survey. BMC Family Practice 2003, 4:15.